TOOMAN CRAIG A
SEC insider (Form 3/4/5 filer). CIK 0001201050. President and CEO at Silence Therapeutics plc (SLN). 1 reported Form 4/5 transaction since Sep 2024; latest on Jan 2, 2025. Located in LONDON, X0.
Companies TOOMAN CRAIG A has filed insider reports for
- Silence Therapeutics plc (SLN): Director, Officer, President and CEO
TOOMAN CRAIG A
CIK: 0001201050
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SLN
Silence Therapeutics plc
DirectorOfficer